ITRAVIL AP 60MG CLOBENZOREX 30 CAPSULES

$180.00$410.00

ITRAVIL AP 60MG CLOBENZOREX 30 CAPSULES

MAIN SUBSTANCE : Clobenzorex

CATEGORY : Weight loss

MANUFACTURER : IFA Celtics

DOSAGE : 1  cap in the morning

PACKAGE :  60mg/cap × 30 capsules

Clear
Add to Wishlist
Add to Wishlist

Description

ITRAVIL AP 60MG CLOBENZOREX 30 CAPSULES

 

Itravil AP 60mg is used for weight loss and is a slimming medicine containing active substances called Clobenzorex and for other conditions.

Itravil AP 60mg is available for oral administration in immediate-release tablets containing 60mg Neobes and in controlled-release tablets containing 60 mg diethylpropion hydrochloride. The inactive ingredients in each immediate-release tablet are: cornstarch, lactose, magnesium stearate, pregelatinized cornstarch, talc, and tartaric acid. The inactive ingredients in each controlled-release tablet are: carbomer 934P, mannitol, povidone, tartaric acid, zinc stearate.

Itravil AP is a sympathomimetic and a central stimulant that is utilized as an anorectic agent in obesity treatments. It belongs to the sympathomimetic amines pharmacological group. It functions to stimulate some sections of the central nervous system, such as the noradrenergic and dopaminergic sections, to reduce hunger and improve metabolism.

The regular use of Itravil AP pills helps obese individuals to not have feelings of excruciating hunger, which can obviously greatly limit their high calorie food consumption. In the first three months of Clobenzorex use, a continuous and significant reduction in body weight is experienced. Afterwards, the weight reduction is considerably slowed down, making the further use of the Clobenzorex pills pointless for most individuals.

 

 

Buy Itravil 30mg online

 

Additional information

Choose an Option

10 BOXES – 300 CAPS, 4 BOXES – 120 CAPS, 5 BOXES – 150 CAPS, 6 BOXES – 180 CAPS, 8 BOXES – 240 CAPS

Reviews

There are no reviews yet.

Be the first to review “ITRAVIL AP 60MG CLOBENZOREX 30 CAPSULES”

Your email address will not be published.